The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

We often don’t know what we are doing, but we can’t stop. Science and research never stop.

Four in five Americans have health insurance, one in four didn’t get a routine checkup last year. Nearly 3.31 million people reported that they have never had a checkup in their life

The rapid evolution of technology, particularly artificial intelligence (AI), robotics, 3D printing, blockchain, the Internet of Things, and 5G, presents a unique dichotomy: they...